Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07600762
PHASE1
A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants
Official title: A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Nacresertib in Healthy Adult Japanese Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2026-04-25
Completion Date
2026-06
Last Updated
2026-05-26
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Nacresertib
Oral tablet
DRUG
Placebo for Nacresertib
Oral tablet
Locations (1)
CenExel ACT- Anaheim Clinical Trials /ID# 282482
Anaheim, California, United States